Amyotrophic lateral sclerosis (Q55877676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

review article

1 reference

title

Amyotrophic lateral sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

21 January 2020

main subject

0 references

author

Martin R. Turner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

Orla Hardiman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

James R Burrell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

2

Steve Vucic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Benjamin C Cheah

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

Andrew Eisen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

Margaret C Zoing

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

Matthew C Kiernan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

4 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

volume

377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

issue

9769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

942-955

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

Maternal age, exposure to siblings, and risk of amyotrophic lateral sclerosis

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Incidence of amyotrophic lateral sclerosis in Europe

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Ethnic variation in the incidence of ALS: a systematic review

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Mutations of optineurin in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Aggregation of neurodegenerative disease in ALS kindreds

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

The natural history of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Excitotoxicity and amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

The natural history of primary lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Progressive apraxia of speech as a sign of motor neuron disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Motor neuron disease: the bare essentials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Fatigue in amyotrophic lateral sclerosis: Frequency and associated factors

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

The management of motor neurone disease.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

The overlap of amyotrophic lateral sclerosis and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Prevalence and patterns of cognitive impairment in sporadic ALS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

A rapid screening battery to identify frontal dysfunction in patients with ALS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Cognitive change in ALS: a prospective study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Molecular biology of amyotrophic lateral sclerosis: insights from genetics

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Clinical aspects of ALS in Gulf War veterans

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Three soccer playing friends with simultaneous amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superox

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Unraveling the mechanisms involved in motor neuron degeneration in ALS

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Excitatory Amino Acid Transmitters

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Excitatory amino acid neurotoxicity and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Ultrastructure of excitotoxic neuronal death in murine cortical culture

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

The role of monoamine metabolism in oxidative glutamate toxicity.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Global loss of Na,K-ATPase and its nitric oxide-mediated regulation in a transgenic mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Lithium delays progression of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Diagnostic investigation and multidisciplinary management in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Polyglucosan body disease myopathy: an unusual presentation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Frequent atrophic groups with mixed-type myofibers is distinctive to motor neuron syndromes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Assessment of disease progression in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Clinical neurophysiology of ALS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Clinical electrophysiology of the upper and lower motor neuron in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Consensus criteria for the diagnosis of multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Electrodiagnostic criteria for diagnosis of ALS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Amyotrophic lateral sclerosis. A study of its presentation and prognosis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Phenotypic variants of autoimmune peripheral nerve hyperexcitability

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Amyotrophic Lateral Sclerosis Mimic Syndromes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and its repercussions

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Biomarkers in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Magnetic resonance imaging in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

The basis of anisotropic water diffusion in the nervous system - a technical review

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Diffusion-based tractography in neurological disorders: concepts, applications, and future developments

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Cognitive impairment in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Consistent resting-state networks across healthy subjects

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Changes of resting state brain networks in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

MRI detection of single particles for cellular imaging.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Imaging inflammation in acute brain ischemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

In vivo tracking of stem cells in brain and spinal cord injury

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Lost in translation: treatment trials in the SOD1 mouse and in human ALS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Minocycline for patients with ALS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Design of phase II ALS clinical trials.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the Am

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Multidisciplinary ALS care improves quality of life in patients with ALS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Managing patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Non-invasive ventilation in ALS: current practice and future role.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Hypermetabolism in ALS: correlations with clinical and paraclinical parameters

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

High metabolic level in patients with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Hypermetabolism in ALS patients: an early and persistent phenomenon.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: a retrospective review of 98 patients in a single centre

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

ALSUntangled Update 1: Investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALS

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

The use of alternative medicine by patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)61156-7

7 January 2021

10.1016/S0140-6736(10)61156-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21296405 AND SRC:MED&resulttype=core&format=json

21 January 2020

1 reference